The legislature of Massachusetts, which in 2008 adopted one of the strictest state laws governing pharmaceutical company interactions with physicians, has passed revisions that would again allow pharma companies to pay for “modest” meals under certain circumstances....More
It looks like the Supreme Court upheld with a 5-4 ruling the individual mandate in the Affordable Care Act. So what does that mean for CME providers and pharma company meeting professionals? I'd say it means we need to stay the course we've been on ......More
Keynote presenters at the 2012 Pharma Forum told participants that meeting managers play pivotal role in their companies' ability to comply with regulations....More
While we struggle here in the U.S. with the uncertainties of what the Sunshine Act will mean for both pharma companies and CME providers, France has been busy promulgating its own version of legislation that seeks to regulate financial transactions ......More
Audience members at a physician panel at the 4th Annual West Coast Life Sciences Meeting Management Forum, held last December in San Diego, were curious to know how docs are learning about new regulations such as those included in the Sunshine Act. Here's what some docs had to say....More
A survey of participants at the Fourth Annual Life Sciences Meeting Management Forum reveal the industry's state of readiness for the implementation of the Sunshine Act....More
The Massachusetts House of Representatives has voted 128-22 to repeal the Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct....More
Pharma meetings may have weathered the recession, but keynoters opening the Pharmaceutical Meeting Management Forum in Philadelphia say more challenges are ahead, including increasing government oversight....More
The Harvard Medical School’s Faculty of Medicine Committee on Conflicts of Interest issued a report last month on its review of the school’s 20-year-old COI policy....More
The Accreditation Council for Continuing Medical Education’s Board of Directors voted at its July meeting to approve a revised process for handling complaints regarding ACCME-accredited providers....More
The uncertain future of the country's healthcare system has direct implications for biopharmaceutical and medical device companies, and in turn will affect the way these companies approach medical meetings and education, said Kim Slocum during a keynote address at the Sixth Annual Pharmaceutical Meeting Management Forum...More
In the past six months, we have seen one or two challenges in our industry, joked Terri Breining, CMP, CMM, CEO and president of Concepts Worldwide Inc.,...More
The AIG effect has hit the pharmaceutical meetings sector. During a closed-door summit for senior-level corporate planners at the Pharmaceutical Meeting...More
With the pharmaceutical industry in flux, the economy in turmoil, and regulations on the rise, third-party meeting managers anticipate tough times ahead....More
A new law in Washington that requires pharmaceutical sales representatives to obtain a special license to sell pharmaceutical products in the District will not affect representatives attending medical meetings or conventions in D.C...More